(Q33321717)

English

Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

object named as

Helenice Gobbi

5

0 references

object named as

Konradin Metze

2

0 references

author name string

Vanessa F Z Marinho

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Fernanda S F Sanches

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Gislene F S Rocha

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

29 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-64

0 references

First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Lymphangiogenesis does not occur in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Lack of lymphangiogenesis during breast carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Lymphangiogenesis and breast cancer metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Vascular growth factors and lymphangiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Lymphangiogenesis and tumor metastasis: myth or reality?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Routinely available indicators of prognosis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2294134

21 June 2018

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-64

21 January 2018

Desmoplakin as a specific marker of lymphatic vessels.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-64

21 January 2018

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-64

21 January 2018

Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-64

21 January 2018

Role of E‐cadherins in development of lymphatic tumor emboli

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-64

21 January 2018

E-cadherin quantitative immunocytochemical assays in breast carcinomas.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-64

21 January 2018

Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prox1 function is required for the development of the murine lymphatic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphatic regeneration: new insights from VEGFR-3 blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphatic vessel density and lymph node metastasis in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphangiogenesis and tumor metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18307818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-8-64

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33321717&oldid=1975746699"